No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SXTP 60 Degrees Pharmaceuticals
- 0.286
- -0.006-2.12%
Trading Jun 3 09:45 ET
3.49MMarket Cap-3323P/E (TTM)
0.295High0.286Low50.21KVolume0.295Open0.292Pre Close14.48KTurnover0.62%Turnover RatioLossP/E (Static)12.21MShares8.65052wk High-1.31P/B2.31MFloat Cap0.20152wk Low--Dividend TTM8.07MShs Float8.650Historical High--Div YieldTTM2.98%Amplitude0.201Historical Low0.288Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
H.C. Wainwright Keeps Their Hold Rating on 60 Degrees Pharmaceuticals, Inc. (SXTP)
Express News | 60 Degrees Pharmaceuticals Inc: Enrollment Will Begin After a Site Initiation Visit in Boston on June 13, 2024
Express News | Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersSharps Technology (NASDAQ:STSS) stock rose 140.0% to $0.51 during Tuesday's regular session. The company's market cap stands at $8.0 million. Insmed (NASDAQ:INSM) stock moved upwards by 112.72%
12 Health Care Stocks Moving In Friday's After-Market Session
GainersSharps Technology (NASDAQ:STSS) shares rose 50.5% to $0.32 during Friday's after-market session. The market value of their outstanding shares is at $5.0 million. Cyclacel Pharmaceuticals (NASDA
Analysts' Opinions Are Mixed on These Healthcare Stocks: 60 Degrees Pharmaceuticals, Inc. (SXTP), GoodRx Holdings (GDRX) and Dianthus Therapeutics (DNTH)
Comments
$60 Degrees Pharmaceuticals (SXTP.US)$ I read the DEF 14A but I don't understand it. It talks about increasing common shares by 5 M but refers to the 2022 plan amendment proposal & a reverse stock split of 1:5 to 1:12. It reports a bunch of other info, but all I care about is how the share price will behave in light of this filing. Can someone smarter than me please take a look at it & let me know. ![]()
$60 Degrees Pharmaceuticals(SXTP.US$ grabbed some . 27's this morning for a swing
$60 Degrees Pharmaceuticals(SXTP.US$
Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
2
$60 Degrees Pharmaceuticals(SXTP.US$ look at that short attack...they jump on every damn thing no matter how low the price is😠
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg